On the public citation graph
EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
0 signed · 97 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.24335openalex-snapshot
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer
inferredcites →https://doi.org/10.1002/ijc.10860openalex-snapshot
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1007/s10549-010-1004-yopenalex-snapshot
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
inferredcites →https://doi.org/10.1007/s10549-013-2620-0openalex-snapshot
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
inferredcites →https://doi.org/10.1007/s12253-008-9132-yopenalex-snapshot
Expression of EphA2 and E-cadherin in Gastric Cancer: Correlated with Tumor Progression and Lymphogenous Metastasis
inferredcites →https://doi.org/10.1007/s12253-009-9221-6openalex-snapshot
Clinical Significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 Receptors in Pancreatic Ductal Adenocarcinoma
inferredcites →https://doi.org/10.1007/s12253-013-9692-3openalex-snapshot
Ephrin Receptor (Eph) -A1, -A2, -A4 and -A7 Expression in Mobile Tongue Squamous Cell Carcinoma: Associations with Clinicopathological Parameters and Patients Survival
inferredcites →https://doi.org/10.1016/b978-0-12-386503-8.00001-6openalex-snapshot
Regulation of Tumor Initiation and Metastatic Progression by Eph Receptor Tyrosine Kinases
inferredcites →https://doi.org/10.1016/j.bbrc.2004.04.102openalex-snapshot
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application
inferredcites →https://doi.org/10.1016/j.canlet.2018.07.030openalex-snapshot
Viewing the Eph receptors with a focus on breast cancer heterogeneity
inferredcites →https://doi.org/10.1016/j.cytogfr.2004.09.002openalex-snapshot
The role of ephrins and Eph receptors in cancer
inferredcites →https://doi.org/10.1016/j.oraloncology.2008.01.018openalex-snapshot
Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: Correlation with the angiogenesis and clinical outcome
inferredcites →https://doi.org/10.1016/j.semcdb.2011.10.014openalex-snapshot
Clinical relevance of Ephs and ephrins in cancer: Lessons from breast, colorectal, and lung cancer profiling
inferredcites →https://doi.org/10.1016/j.ygyno.2004.05.019openalex-snapshot
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
inferredcites →https://doi.org/10.1038/modpathol.2010.33openalex-snapshot
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
inferredcites →https://doi.org/10.1038/nature03626openalex-snapshot
EphB receptor activity suppresses colorectal cancer progression
inferredcites →https://doi.org/10.1038/nrc2806openalex-snapshot
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
inferredcites →https://doi.org/10.1038/nrclinonc.2016.66openalex-snapshot
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
inferredcites →https://doi.org/10.1038/nrd4175openalex-snapshot
Therapeutic targeting of EPH receptors and their ligands
inferredcites →https://doi.org/10.1038/onc.2009.18openalex-snapshot
EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells
inferredcites →https://doi.org/10.1038/onc.2014.475openalex-snapshot
The origin of breast tumor heterogeneity
inferredcites →https://doi.org/10.1038/onc.2017.170openalex-snapshot
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
inferredcites →https://doi.org/10.1038/s41388-018-0228-xopenalex-snapshot
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
inferredcites →https://doi.org/10.1038/s41598-017-14549-9openalex-snapshot
Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration
inferredcites →https://doi.org/10.1038/sj.cgt.7700761openalex-snapshot
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1
inferredcites →https://doi.org/10.1038/sj.onc.1204004openalex-snapshot
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
inferredcites →https://doi.org/10.1038/sj.onc.1208937openalex-snapshot
A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis
inferredcites →https://doi.org/10.1056/nejmra0801289openalex-snapshot
Gene-Expression Signatures in Breast Cancer
inferredcites →https://doi.org/10.1093/annonc/mdv221openalex-snapshot
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
inferredcites →https://doi.org/10.1093/annonc/mdx308openalex-snapshot
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
inferredcites →https://doi.org/10.1093/neuonc/nor102openalex-snapshot
Role of Eph/ephrin tyrosine kinase in malignant glioma
inferredcites →https://doi.org/10.1097/pap.0000000000000084openalex-snapshot
Triple-negative Breast Carcinoma
inferredcites →https://doi.org/10.1101/cshperspect.a009159openalex-snapshot
Eph Receptor Signaling and Ephrins
inferredcites →https://doi.org/10.1111/his.12095openalex-snapshot
An immunohistochemical evaluation of the proteins W nt1 and glycogen synthase kinase ( GSK )‐3β in invasive breast carcinomas
inferredcites →https://doi.org/10.1111/his.12795openalex-snapshot
Biomarker assessment and molecular testing for prognostication in breast cancer
inferredcites →https://doi.org/10.1111/j.1365-2559.1991.tb00229.xopenalex-snapshot
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
inferredcites →https://doi.org/10.1111/j.1582-4934.2012.01612.xopenalex-snapshot
Eph receptors and ephrins as targets for cancer therapy
inferredcites →https://doi.org/10.1126/scisignal.aan4667openalex-snapshot
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
inferredcites →https://doi.org/10.1136/jcp.2006.041194openalex-snapshot
Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis
inferredcites →https://doi.org/10.1139/o10-145openalex-snapshot
Dancing with the dead: Eph receptors and their kinase-null partnersThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.
inferredcites →https://doi.org/10.1146/annurev-pharmtox-011112-140226openalex-snapshot
Eph Receptors and Ephrins: Therapeutic Opportunities
inferredcites →https://doi.org/10.1158/0008-5472.can-09-1710openalex-snapshot
The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-09-1845openalex-snapshot
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
inferredcites →https://doi.org/10.1158/0008-5472.can-15-0847openalex-snapshot
The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.226.11.1openalex-snapshot
Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-03-0589openalex-snapshot
EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma
inferredcites →https://doi.org/10.1158/1535-7163.mct-12-0030openalex-snapshot
Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion
inferredcites →https://doi.org/10.1172/jci33154openalex-snapshot
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
inferredcites →https://doi.org/10.1172/jci45014openalex-snapshot
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
inferredcites →https://doi.org/10.1177/0897190012442062openalex-snapshot
Triple Negative Breast Cancer: A Brief Review of its Characteristics and Treatment Options
inferredcites →https://doi.org/10.1186/1471-2407-8-79openalex-snapshot
Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
inferredcites →https://doi.org/10.1186/1472-6890-14-8openalex-snapshot
Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival
inferredcites →https://doi.org/10.1186/bcr2207openalex-snapshot
Eph receptors in breast cancer: roles in tumor promotion and tumor suppression
inferredcites →https://doi.org/10.1200/jco.2005.23.16_suppl.9583openalex-snapshot
Overexpression of EphA2 gene in invasive human breast cancer and its association with hormone receptor status
inferredcites →https://doi.org/10.1200/jco.2007.15.5986openalex-snapshot
Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma
inferredcites →https://doi.org/10.1245/s10434-014-4279-0openalex-snapshot
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.12659/msm.881929openalex-snapshot
Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: An immunohistochemical study
inferredcites →https://doi.org/10.1309/ajcpiv9iq1mrqmooopenalex-snapshot
Molecular Pathology of Breast Cancer
inferredcites →https://doi.org/10.1371/journal.pone.0002994openalex-snapshot
Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets
inferredcites →https://doi.org/10.1371/journal.pone.0024426openalex-snapshot
Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome
inferredcites →https://doi.org/10.18632/oncotarget.7246openalex-snapshot
EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer
inferredcites →https://doi.org/10.3322/caac.21393openalex-snapshot
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
inferredcites →https://doi.org/10.3390/ijms22168412openalex-snapshot
The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
inferredcites →https://doi.org/10.3748/wjg.14.5650openalex-snapshot
Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers
inferredcites →https://doi.org/10.3892/or.11.3.605openalex-snapshot
Expression of EphA2 and E-cadherin in colorectal cancer: Correlation with cancer metastasis
inferredcites →https://doi.org/10.3892/or.19.1.151openalex-snapshot
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
inferredcites →https://doi.org/10.4161/cam.20154openalex-snapshot
The multifaceted roles of Eph/ephrin signaling in breast cancer
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5022615openalex-extracted
An Anti-Human Epha2 Monoclonal Antibody Ea2mab-7 Shows High Sensitivity for Flow Cytometry, Western Blot, and Immunohistochemical Analyses
inferred← citeshttps://doi.org/10.1002/cbf.4128openalex-snapshot
TYRO3 and EPHA2 Expression Are Dysregulated in Breast Cancer
inferred← citeshttps://doi.org/10.1007/s00432-024-05711-8openalex-snapshot
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway
inferred← citeshttps://doi.org/10.1007/s12020-024-04079-6openalex-snapshot
Immunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature
inferred← citeshttps://doi.org/10.1016/j.arabjc.2022.104211openalex-snapshot
Evaluation of a novel EphA2 targeting peptide for triple negative breast cancer based on radionuclide molecular imaging
inferred← citeshttps://doi.org/10.1016/j.bbcan.2022.188828openalex-snapshot
Crosstalk between the peripheral nervous system and breast cancer influences tumor progression
inferred← citeshttps://doi.org/10.1016/j.bbrep.2025.101998openalex-snapshot
Development of an anti-human EphA2 monoclonal antibody Ea2Mab-7 for multiple applications
inferred← citeshttps://doi.org/10.1016/j.cej.2025.171773openalex-snapshot
Genetically engineered nanovesicles based anti-EphA2/CD3 bispecific antibody promotes T cell immune response for triple negative breast cancer treatment
inferred← citeshttps://doi.org/10.1016/j.fmre.2024.03.005openalex-snapshot
GWASTool: A web pipeline for detecting SNP-phenotype associations
inferred← citeshttps://doi.org/10.1016/j.heliyon.2025.e42293openalex-snapshot
The neuroscience in breast cancer: Current insights and clinical opportunities
inferred← citeshttps://doi.org/10.1016/j.isci.2023.108395openalex-snapshot
Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.tranon.2026.103074openalex-snapshot
Soluble N-terminal EphA2 fragment as a diagnostic biomarker and functional mediator of tumor progression in triple-negative breast cancer
inferred← citeshttps://doi.org/10.1021/acsomega.2c07849openalex-snapshot
Novel [111In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA2
inferred← citeshttps://doi.org/10.1186/s12967-026-07870-3openalex-snapshot
Unlocking the potential of EphA2 with precision-guided cancer therapy: bicycle drug conjugates
inferred← citeshttps://doi.org/10.1186/s40164-023-00463-6openalex-snapshot
ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells
inferred← citeshttps://doi.org/10.2147/ijwh.s406327openalex-snapshot
Molecular Mechanisms Behind Vascular Mimicry as the Target for Improved Breast Cancer Management
inferred← citeshttps://doi.org/10.21873/cgp.20447openalex-snapshot
Engineering of an EPHA2-Targeted Monobody for the Detection of Colorectal Cancer
inferred← citeshttps://doi.org/10.29413/abs.2026-11.2.14openalex-snapshot
Gene expression markers predicting hematogenous metastasis for HER2-negative breast cancer treatment with taxane-containing neoadjuvant chemotherapy
inferred← citeshttps://doi.org/10.3389/fonc.2025.1620122openalex-snapshot
EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway
inferred← citeshttps://doi.org/10.3390/cancers15020403openalex-snapshot
Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers
inferred← citeshttps://doi.org/10.3390/cancers15133434openalex-snapshot
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
inferred← citeshttps://doi.org/10.3390/cancers15153963openalex-snapshot
EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets
inferred← citeshttps://doi.org/10.3390/ijms232314695openalex-snapshot
An Overview of the Molecular Cues and Their Intracellular Signaling Shared by Cancer and the Nervous System: From Neurotransmitters to Synaptic Proteins, Anatomy of an All-Inclusive Cooperation
inferred← citeshttps://doi.org/10.3390/ijms25073780openalex-snapshot
Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy
inferred← citeshttps://doi.org/10.3390/ijms25073834openalex-snapshot
The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies
inferred← citeshttps://doi.org/10.3390/ijms252212191openalex-snapshot
EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities
inferred← citeshttps://doi.org/10.3390/radiation6040036openalex-snapshot
Exploratory Transcriptomic Profiling of Triple-Negative Breast Cancer Patient-Derived Organoids Following Treatment with Radiation Alone and in Combination with Polo-like Kinase 4 Inhibition
inferred← citeshttps://doi.org/10.6084/m9.figshare.26651691openalex-snapshot
Additional file 1 of ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.